Business Description
HilleVax Inc
NAICS : 541714
SIC : 2834
Description
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.99 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.17 | |||||
| 9-Day RSI | 39.42 | |||||
| 14-Day RSI | 43.25 | |||||
| 6-1 Month Momentum % | -25.69 | |||||
| 12-1 Month Momentum % | -29.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.8 | |||||
| Quick Ratio | 13.8 | |||||
| Cash Ratio | 13.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 12.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -35.16 | |||||
| ROA % | -29.59 | |||||
| ROIC % | -369.74 | |||||
| ROC (Joel Greenblatt) % | -360.96 | |||||
| ROCE % | -30.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.3 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| EV-to-EBIT | -4.69 | |||||
| EV-to-EBITDA | -4.74 | |||||
| EV-to-FCF | -5.18 | |||||
| Price-to-Net-Current-Asset-Value | 2.72 | |||||
| Price-to-Net-Cash | 2.85 | |||||
| Earnings Yield (Greenblatt) % | -21.32 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HLVX
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HilleVax Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.46 | ||
| Beta | 0 | ||
| Volatility % | 45.73 | ||
| 14-Day RSI | 43.25 | ||
| 14-Day ATR ($) | 0.86744 | ||
| 20-Day SMA ($) | 13.4365 | ||
| 12-1 Month Momentum % | -29.46 | ||
| 52-Week Range ($) | 11.35 - 23.1 | ||
| Shares Outstanding (Mil) | 48.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HilleVax Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HilleVax Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HilleVax Inc Frequently Asked Questions
What is HilleVax Inc(HLVX)'s stock price today?
The current price of HLVX is $12.83. The 52 week high of HLVX is $23.10 and 52 week low is $11.35.
When is next earnings date of HilleVax Inc(HLVX)?
The next earnings date of HilleVax Inc(HLVX) is 2023-11-10 Est..
Does HilleVax Inc(HLVX) pay dividends? If so, how much?
HilleVax Inc(HLVX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers